Literature DB >> 29874576

Schwann-Cell-Specific Deletion of Phosphatidylinositol 4-Kinase Alpha Causes Aberrant Myelination.

Alejandro Alvarez-Prats1, Ivana Bjelobaba2, Zane Aldworth3, Takashi Baba1, Daniel Abebe1, Yeun Ju Kim1, Stanko S Stojilkovic2, Mark Stopfer3, Tamas Balla4.   

Abstract

Active membrane remodeling during myelination relies on phospholipid synthesis and membrane polarization, both of which are known to depend on inositol phospholipids. Here, we show that sciatic nerves of mice lacking phosphatidylinositol 4-kinase alpha (PI4KA) in Schwann cells (SCs) show substantially reduced myelin thickness with grave consequences on nerve conductivity and motor functions. Surprisingly, prolonged inhibition of PI4KA in immortalized mouse SCs failed to decrease plasma membrane phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) levels or PI 3-kinase (PI3K) activation, in spite of large reductions in plasma membrane PI4P levels. Instead, it caused rearrangements of the actin cytoskeleton, which was also observed in sciatic nerves of knockout animals. PI4KA inactivation disproportionally reduced phosphatidylserine, phosphatidylethanolamine, and sphingomyelin content in mutant nerves, with similar changes observed in SCs treated with a PI4KA inhibitor. These studies define a role for PI4KA in myelin formation primarily affecting metabolism of key phospholipids and the actin cytoskeleton. Published by Elsevier Inc.

Entities:  

Keywords:  PI 3-kinase; Schwann cell; actin; myelination; phosphatidylinositol; phosphatidylinositol 4-kinase; phosphatidylserine; sciatic nerve

Mesh:

Substances:

Year:  2018        PMID: 29874576      PMCID: PMC7268203          DOI: 10.1016/j.celrep.2018.05.019

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  18 in total

1.  A large scale high-throughput screen identifies chemical inhibitors of phosphatidylinositol 4-kinase type II alpha.

Authors:  Nivedita Sengupta; Marko Jović; Elena Barnaeva; David W Kim; Xin Hu; Noel Southall; Milan Dejmek; Ivana Mejdrova; Radim Nencka; Adriana Baumlova; Dominika Chalupska; Evzen Boura; Marc Ferrer; Juan Marugan; Tamas Balla
Journal:  J Lipid Res       Date:  2019-01-09       Impact factor: 5.922

2.  A Golgi-associated lipid kinase controls peripheral nerve myelination.

Authors:  York Posor; Volker Haucke
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-13       Impact factor: 11.205

3.  Disruption of Endosomal Sorting in Schwann Cells Leads to Defective Myelination and Endosomal Abnormalities Observed in Charcot-Marie-Tooth Disease.

Authors:  John W McLean; Julie A Wilson; Tina Tian; Jennifer A Watson; Mary VanHart; Andrew J Bean; Steven S Scherer; David K Crossman; Eroboghene Ubogu; Scott M Wilson
Journal:  J Neurosci       Date:  2022-05-19       Impact factor: 6.709

4.  Stochastic Epigenetic Mutations Influence Parkinson's Disease Risk, Progression, and Mortality.

Authors:  Gary K Chen; Qi Yan; Kimberly C Paul; Cynthia D J Kusters; Aline Duarte Folle; Melissa Furlong; Adrienne Keener; Jeff Bronstein; Steve Horvath; Beate Ritz
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

5.  Myelination of peripheral nerves is controlled by PI4KB through regulation of Schwann cell Golgi function.

Authors:  Takashi Baba; Alejandro Alvarez-Prats; Yeun Ju Kim; Daniel Abebe; Steve Wilson; Zane Aldworth; Mark A Stopfer; John Heuser; Tamas Balla
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-26       Impact factor: 11.205

Review 6.  Myelin Biology.

Authors:  Alessandra Bolino
Journal:  Neurotherapeutics       Date:  2021-07-09       Impact factor: 6.088

Review 7.  Recent advances in understanding phosphoinositide signaling in the nervous system.

Authors:  Eamonn James Dickson
Journal:  F1000Res       Date:  2019-03-12

Review 8.  The expanding spectrum of neurological disorders of phosphoinositide metabolism.

Authors:  Jonathan R Volpatti; Almundher Al-Maawali; Lindsay Smith; Aqeela Al-Hashim; Julie A Brill; James J Dowling
Journal:  Dis Model Mech       Date:  2019-08-13       Impact factor: 5.758

9.  Conditional Inactivation of Nf1 and Pten in Schwann Cells Results in Abnormal Neuromuscular Junction Maturation.

Authors:  Xiao-Xiao Li; Shi-Jie Zhang; Amy P Chiu; Lilian H Lo; Jeffery C To; He-Ning Cui; Dewi K Rowlands; Vincent W Keng
Journal:  G3 (Bethesda)       Date:  2019-01-09       Impact factor: 3.154

10.  Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation.

Authors:  Naoto Matsumoto; Natsumi Watanabe; Noriko Iibe; Yuriko Tatsumi; Kohei Hattori; Yu Takeuchi; Hiroaki Oizumi; Katsuya Ohbuchi; Tomohiro Torii; Yuki Miyamoto; Junji Yamauchi
Journal:  Biochem Biophys Rep       Date:  2019-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.